Symic Biomedical
SYMIC Biomedical, Inc operates in the healthcare industry focusing on biotechnology business The company studies treatments for.
Launch date
Employees
Market cap
-
Enterprise valuation
€40—60m (Dealroom.co estimates Apr 2019.)
Emeryville California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$1.4m | Debt | ||
* | $270k | Grant | |
$15.0m | Series A | ||
$1.5m | Grant | ||
$25.0m | Series A | ||
$30.0m | Series B | ||
$11.0m | Series C | ||
| Total Funding | €75.2m | ||
Related Content
Recent News about Symic Biomedical
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.